NPCE vs PMI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PMI Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Picard Medical, Inc. (PMI) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while NPCE counters with relative strength in Valuation. Fundamentally, NPCE trades at 90.9x Forward P/E with -9.6% operating margin (-1.1% YoY revenue) versus PMI at N/M Forward P/E and -248.1% operating margin (+38.6% YoY). In options structure, NPCE sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro) against PMI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | NPCE Revenue | PMI Revenue | NPCE Op. Margin | PMI Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2020 | $40M | N/A | -31.7% | N/A | NPCE |
| FY2021 | $50M | N/A | -52.5% | N/A | NPCE |
| FY2022 | $50M | N/A | -89.6% | N/A | NPCE |
| FY2023 | $70M | N/A | -41.5% | N/A | NPCE |
| FY2024 | $80M | $0M | -27.1% | -312.3% | NPCE |
| FY2025 | $100M | $0M | -16.3% | -268.4% | NPCE |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NPCE | PMI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $283.2M | $17.1M | Larger Scale | NPCE |
| Trailing P/E Ratio Valuation | 90.9x | 2.9x | Lower Multiple | PMI |
| Forward P/E Ratio Valuation | 90.9x | N/M | Lower Multiple | NPCE |
| Revenue Growth (YoY) Growth | -1.1% | +38.6% | Higher Growth | PMI |
| Operating Margin (TTM) Profitability | -9.6% | -248.1% | Higher Margin | NPCE |
| Net Profit Margin Profitability | -17.7% | 0.0% | Higher Margin | PMI |
| Return on Equity (ROE) Capital Efficiency | -97.0% | 0.0% | Higher ROE | PMI |
| 52-Week Range Position Momentum | 19% ($5โ$20) | 34% ($0โ$18) | Stronger Trend | PMI |
| Beta / 30D Volatility Risk Regime | 1.22ฮฒ ยท 136% Vol | 54.06ฮฒ ยท 134% Vol | Lower Realized Risk | PMI |
| Unified Institutional Score Composite Signal | 48.8 / 100 (HOLD) | 48.4 / 100 (HOLD) | Higher Composite | NPCE |